# Prophylactic Antimalarial Activity of DB289 in Volunteers

> **NCT00408369** · PHASE1,PHASE2 · COMPLETED · sponsor: **Immtech Pharmaceuticals, Inc** · enrollment: 19 (estimated)

## Conditions studied

- Prophylactic Activity Against Malaria

## Interventions

- **DRUG:** DB289

## Key facts

- **NCT ID:** NCT00408369
- **Lead sponsor:** Immtech Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 19 (ESTIMATED)
- **Last updated:** 2008-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00408369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00408369, "Prophylactic Antimalarial Activity of DB289 in Volunteers". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00408369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*